Trading Window Closed Ahead of Half-Yearly Results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹6.89

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%—

Healthcare Service Provider peers, median of 28sector-1.8%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-1.3—-1.2—

Next day

—-1.3—-1.8—

—+0.0—-1.9—

-4.9-0.2-4.7-2.2-2.7

-6.4-3.0-3.4-4.3-2.1

-11.5-2.7-8.7-2.6-8.9

+3.3-1.7+5.1-5.0+8.3

15d

—-8.9—-5.8—

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Lalchandani Labs has closed its trading window from October 1, 2026, for all directors, promoters, designated persons, and connected persons under the SEBI Insider Trading Regulations. The window will reopen 48 hours after the company declares its unaudited financial results for the half year ended September 30, 2026. The board meeting date for considering these results will be communicated separately. This is a routine compliance filing ahead of the H1 FY26 earnings announcement.

Likely market impact

Routine regulatory compliance. Signals upcoming H1 FY26 results; no direct impact on shareholders or stock price.